Related Experiment Video
Updated: Aug 15, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
p16INK4A expression in cervical premalignant and malignant lesions
Ana Paula Franco Lambert1, Fernando Anschau, Virgínia Minghelli Schmitt
1Laboratório de Biologia Molecular do Instituto de Pesquisas Biomédicas, Pontifícia Universidade Católica do Rio Grande do Sul, Rua Prof. Cristiano Fischer 1118/201, Jardim do Salso, Porto Alegre/RS, CEP 91410-000, Brazil. analambert@gmail.com
Abstract:
p16INK4a is a cyclin-dependent kinase (CDK) inhibitor which decelerates cell cycle by inactivating CDKs that phosphorylate pRb. Human Papillomavirus persistent infection plays an important role on cervical carcinogenesis, mainly by the action of two viral oncoproteins, E6 and E7, which interact with p53 and pRb, respectively. Increasing expression of E6 and E7 in dysplastic cervical cells might thus be reflected by increased expression of p16INK4a. Recent studies revealed that p16INK4a expression could be a marker for dysplastic and neoplastic cervical cells. The aim of this study was to analyze p16INK4a expression in cervical preneoplastic and neoplastic lesions and correlate with lesion grade. Expression of p16INK4a was analyzed by immunohistochemistry. A total of 6 low-grade squamous intraepithelial lesion (LSIL), 21 high-grade squamous intraepithelial lesions (HSIL) and 27 cancer samples were studied. In HPV-positive cervical samples (n=48), p16INK4a expression was observed in 1 of 3 LSIL, in 18 of 19 HSIL and in all 26 cancer cases. These results are in accordance with the hypothesis that functional inactivation of pRb by HPV-E7 protein induces p16INK4a expression in cervical lesions. In our study, a statistically significant association was observed between cervical lesion grade and p16INK4a expression (P<0.001).
Insights
p16INK4a protein expression increases with cervical lesion severity. This biomarker is significantly associated with higher grades of cervical dysplasia and cancer, aiding in diagnosis.
Area of Science:
- Oncology
- Cell Biology
- Virology
Background:
- Persistent Human Papillomavirus (HPV) infection is a key factor in cervical carcinogenesis.
- HPV oncoproteins E6 and E7 interact with tumor suppressors p53 and pRb, respectively.
- p16INK4a, a cyclin-dependent kinase inhibitor, decelerates the cell cycle by inactivating CDKs that phosphorylate pRb.
Purpose of the Study:
- To investigate p16INK4a expression in cervical preneoplastic and neoplastic lesions.
- To correlate p16INK4a expression levels with the grade of cervical lesions.
- To assess the utility of p16INK4a as a biomarker in cervical dysplasia.
Main Methods:
- Immunohistochemistry was employed to analyze p16INK4a expression.
- Cervical samples included low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL), and invasive cervical cancer.
- Expression patterns were analyzed in HPV-positive samples.
Main Results:
- p16INK4a expression was detected in a significant proportion of HSIL (18/19) and all analyzed cancer cases (26/26).
- Expression was observed in 1 of 3 LSIL cases.
- A statistically significant association (P<0.001) was found between cervical lesion grade and p16INK4a expression.
Conclusions:
- Increased p16INK4a expression correlates with the progression of cervical lesions.
- HPV oncoprotein E7-mediated pRb inactivation likely induces p16INK4a upregulation.
- p16INK4a serves as a valuable marker for identifying and grading cervical dysplasia and cancer.
Related Concept Videos
Abnormal Proliferation
Cellular Adaptation IV: Dysplasia and Metaplasia
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Inhibition of Cdk Activity
